Thomas Alfred Inglin

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: The Procter Gamble Company, The Cleveland Clinic Foundation. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Alfred Inglin. Retrieved from https://idiyas.com/inventor/thomas-alfred-inglin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 184(Granted Patents)

Location History:

Hamilton, OH (US) (1994 - 1998)
Loveland, OH (US) (2014 - 2020)

Company Filing History:

9 out of 17,173

The Procter Gamble Company

patents

2 out of 1,074

The Cleveland Clinic Foundation

patents

where one patent can have more than one assignee

Years Active: 1994-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10786479 - Methods for inhibiting conversion of carnitine to trimethylamine (TMA) (2020-09-29),

2. 10780072 - Methods for inhibiting conversion of choline to trimethylamine (TMA) (2020-09-22),

3. 9526673 - Blister cards promoting intuitive dosing (2016-12-27),

4. 9445970 - Blister cards promoting intuitive dosing (2016-09-20),

5. 9314402 - Blister cards promoting intuitive dosing (2016-04-19),

6. 8905237 - Blister cards promoting intuitive dosing (2014-12-09),

7. 8752704 - Blister cards promoting intuitive dosing (2014-06-17),

8. 5733272 - Absorbent articles for odor control with positive scent signal (1998-03-31),

9. 5368926 - Fluid accepting, transporting, and retaining structure (1994-11-29),

Title: The Innovations of Thomas Alfred Inglin

Introduction

Thomas Alfred Inglin is a notable inventor based in Loveland, Ohio. He holds a total of nine patents, showcasing his contributions to the field of science and technology. His work primarily focuses on methods that impact human health and nutrition.

Latest Patents

Among his latest patents are innovative methods for inhibiting the conversion of carnitine and choline to trimethylamine (TMA). The first patent provides a method to inhibit the conversion of carnitine to TMA, which is crucial for lowering TMAO levels in individuals. This method involves administering specific compositions that effectively inhibit this conversion. The second patent addresses the conversion of choline to TMA, offering a similar approach to lower TMAO levels through the administration of effective compounds.

Career Highlights

Throughout his career, Thomas has worked with prominent organizations, including The Procter & Gamble Company and The Cleveland Clinic Foundation. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing significantly to his field.

Collaborations

Some of his notable coworkers include Angela Jane Deutsch and Rosa Manuela Leon Alonso. Their collaboration has likely enriched the research and development processes in which they have been involved.

Conclusion

Thomas Alfred Inglin's contributions to innovation, particularly in health-related methods, highlight his role as a significant inventor. His patents reflect a commitment to improving human health through scientific advancements.

Profile summary based on public USPTO records.